000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)

A du Bois ; Schroeder, W ; Jelic, S ; Weber, B ; Sehouli, J ; Keern, J ; Priou, F ; Huober, J ; Railing, M ; Ray-Coquard, I ; Heilmann, V ; Surges, A ; Pfisterer, J ; Gropp, M ; Staehle, A ; Wimberger, P ; Jackisch, C ; Mueller, H H

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]

Oxford: BMJ Publishing Group LTD

Texto completo disponível